Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades.
Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $54,880, and 8 were calls, valued at $1,131,419.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $100.0 to $180.0 for Johnson & Johnson over the recent three months.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale activity within a strike price range from $100.0 to $180.0 in the last 30 days.
Johnson & Johnson Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | TRADE | NEUTRAL | 01/19/24 | $100.00 | $663.7K | 169 | 125 |
| JNJ | CALL | SWEEP | BULLISH | 01/17/25 | $160.00 | $134.6K | 758 | 137 |
| JNJ | CALL | TRADE | BEARISH | 01/17/25 | $180.00 | $102.9K | 2.6K | 3 |
| JNJ | CALL | SWEEP | BULLISH | 03/15/24 | $140.00 | $85.2K | 270 | 62 |
| JNJ | CALL | SWEEP | NEUTRAL | 04/19/24 | $150.00 | $41.8K | 1.4K | 47 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Present Market Standing of Johnson & Johnson
- With a volume of 3,065,179, the price of JNJ is down -0.33% at $152.0.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 57 days.
What Analysts Are Saying About Johnson & Johnson
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $215.0.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $215.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
